OncoTriage. Поиск наилучшего лечения для вашего пациента

Гемостаз и тромбозы

НОВАЯ СТАТЬЯ

Ultrasound-Guided Modified Out-of-Plane Approach With Micro-Convex Probe for Stellate Ganglion Block in Patient With Refractory Ventricular Tachycardia With Anticoagulation: A Case Report.

Stellate ganglion block (SGB) is effective in treating refractory ventricular tachycardia...

DOI: 10.1213/XAA.0000000000001952

Hamamatsu Y, Takechi K, Mido T

A&A practice, 2025-04-04

НОВАЯ СТАТЬЯ

Efficacy and Safety of Topical Compound Heparin Sodium Allantoin Gel (Main Components: Onion Extract Quercetin) for the Treatment of Rosacea.

Compound heparin sodium allantoin gel effectively improved facial erythema, alleviated ithching and burning sensations, and improved patients' quality of life.

DOI: 10.1111/jocd.70129

Xu Z, Yu B, Qing Y, Ye S, Xu B, Wang Y, Zhao B, Sun H, Wu N, Wu J

Journal of cosmetic dermatology, 2025-04-04

НОВАЯ СТАТЬЯ

Low Molecular Weight Heparin Dosing in Relation to Postoperative Bleeding After Tracheotomy in Patients Infected With SARS-CoV-2-A Descriptive Study.

Decreased doses of LMWH on the day of surgery were not associated with a risk reduction for post-surgical bleeding in patients with SARS-CoV-2 who received tracheotomy. Increasing age was a risk factor for post-surgical bleeding.

DOI: 10.1002/lio2.70122

Victorin D, Bergquist H, Hafsten L, Nihlén Å, Lindell E

Laryngoscope investigative otolaryngology, 2025-04-04

НОВАЯ СТАТЬЯ

Prothrombin time predicting time-dependent and risk-stratified mortality in polytrauma patients.

There are early and significant differences in mortality according to PT values in polytrauma patients (despite resuscitation measures), urging for a fast correction of PT. Time-dependent and stratified referencing may help clinicians estimate the mortality risk and decide upon the extent of surgical care.

DOI: 10.1186/s12245-025-00841-3

Vetter P, Niggli C, Hambrecht J, Haschtmann D, Pape HC, Mica L

International journal of emergency medicine, 2025-04-04

НОВАЯ СТАТЬЯ

FDA approves siRNA drug for haemophilia prophylaxis.

У данной статьи нет абстракта.

DOI: 10.1038/d41573-025-00066-2

Mullard A

Nature reviews. Drug discovery, 2025-04-04

НОВАЯ СТАТЬЯ

Chronic Coronary Syndrome and New-Onset Atrial Fibrillation or Venous Thromboembolism: How Best to Manage Antithrombotic Therapy Strategies.

The antithrombotic therapy (AT) regime for patients with atrial fibrillation (AF) or venous thromboembolism (VTE) who are in the chronic phase after percutaneous coronary intervention (PCI), either elective or in the context of an acute coronary syndrome (ACS), i.e...

DOI: 10.1093/ehjcvp/pvaf021

Rubboli A, Angiolillo DJ, Becattini C, Lip GYH

European heart journal. Cardiovascular pharmacotherapy, 2025-04-04

НОВАЯ СТАТЬЯ

Sex Differences Regarding the Risk of Incident Venous Thromboembolism in Hospitalized Patients with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Female sex was found to be an independent risk factor for VTE and some sex-specific risk factors exist among inpatients with AECOPD. These findings highlight the importance of considering sex and sex-related factors when assessing the VTE risk in AECOPD patients.

DOI: 10.5551/jat.65451

Pu J, Yi Q, Luo Y, Wei H, Ge H, Liu H, Zhang J, Li X, Pan P, Xie X, Yi M, Cheng L, Zhou H, Zhang J, Peng L, Zeng J, Chen X, Zhou H,

Journal of atherosclerosis and thrombosis, 2025-04-04

НОВАЯ СТАТЬЯ

A prospective, multicenter, randomized controlled trial evaluating anticoagulation alone vs anticoagulation plus computer assisted vacuum thrombectomy for the treatment of intermediate-high-risk acute pulmonary embolism: Rationale and design of the STORM-PE study.

The STORM-PE trial will help inform future guidelines and standards of care related to frontline treatment using mechanical thrombectomy with CAVT for patients with acute intermediate-high-risk PE.

DOI: 10.1016/j.ahj.2025.03.018

Rosovsky RP, Konstantinides SV, Moriarty JM, Dohad SY, Weinberg I, Parikh SA, Channick R, Lookstein RA

American heart journal, 2025-04-04

НОВАЯ СТАТЬЯ

Behavior of Soluble C-type Lectin-Like Receptor 2 levels in Patients with Coronavirus Disease 2019-associated with Thrombosis.

Elevation of the super formula of sCLEC-2xD-dimer/platelet count was associated with the thrombosis in patients with COVID-19 suggesting the thrombosis in COVID-19 may be caused by the development of microthrombosis.

DOI: 10.1055/a-2572-1170

Wada H, Shiraki K, Ichkawa Y, Ito N, Inoue H, Moritani I, Masuda J, Yamamoto A, Tomida M, Yoshida M, Kawamura M, Shimaoka M, Iba T, Shimpo H

Thrombosis and haemostasis, 2025-04-04

НОВАЯ СТАТЬЯ

Efficacy and safety of oral anticoagulants in patients with atrial fibrillation and acute myocardial infarction: a systematic review and meta-analysis.

OAC therapy is effective for patients with AF and AMI, but should be administered cautiously in those at high bleeding risk.

DOI: 10.1093/postmj/qgaf046

Zheng Y, Zheng X, Bazoukis G, Tse G, Liu T

Postgraduate medical journal, 2025-04-04

НОВАЯ СТАТЬЯ

Trends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry.

In 2022, 44% of SHA-PUPs and 25% of SHA-PTPs received emicizumab prophylaxis. Concomitantly, observed inhibitor incidence reduced to 6% in SHA-PUPs. In SHB, EHL-rFIX treatment increased to 79% in SHB-PUPs and 69% in SHB-PTPs. Assessing inhibitor incidence for new concentrates is likely to be hampered by novel treatments causing delayed exposure to FVIII/FIX.

DOI: 10.1111/hae.70039

Fischer K, Lassila R, Peyvandi F, Gatt A, Gouw SC, Hollingsworth R, Lambert T, Kaczmarek R, Carbonero D, Makris M,

Haemophilia : the official journal of the World Federation of Hemophilia, 2025-04-04

НОВАЯ СТАТЬЯ

Reversal of Factor Xa Inhibitor-Related Intracranial Hemorrhage: A Multicenter, Retrospective, Observational Study Comparing the Efficacy and Safety of Andexanet and Prothrombin Complex Concentrates.

Despite statistically higher odds of achieving hemostatic efficacy with andexanet, we also observed higher odds of a TE with no difference in discharge outcomes observed between groups. When those with more severe neurologic injuries were excluded, efficacy and safety outcomes were similar between treatments.

DOI: 10.1097/CCM.0000000000006656

Panos NG, Jones GM, Cook AM, Peksa GD, John S, DeMott JM, Tobias P, Da Silva I,

Critical care medicine, 2025-04-04

НОВАЯ СТАТЬЯ

Real-world evidence comparing oral anticoagulants for NVAF in Europe: a systematic review and network meta-analysis.

This NMA provides valuable insights into the real-world effectiveness and safety of DOACs and VKAs in Europe, supporting clinical decision-making and adding to the existing evidence base from clinical trials.

DOI: 10.1080/14796678.2025.2484119

Cichewicz A, Jawla S, Zuchinali P, Akin-Fajiye M, Massierer D, Porto I, Garcia-Moll X

Future cardiology, 2025-04-04

НОВАЯ СТАТЬЯ

Risk factors associated with venous thromboembolism after hepatectomy in oncology patients.

Major resection and increased EBL are associated with higher risk of VTE. These patients may warrant more intensive prophylax compared to those having minor resections with minimal blood loss.

DOI: 10.1016/j.hpb.2024.12.021

Greenberg B, Acher AW, Branes A, Roke R, Xu G, Lafreniere-Roula M, Thorpe K, Xu K, Karanicolas PJ,

HPB : the official journal of the International Hepato Pancreato Biliary Association, 2025-04-04

НОВАЯ СТАТЬЯ

Aspirin Is as Effective and Safe as Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Joint Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Based on high-quality evidence from RCTs, aspirin is as effective and safe as OACs in preventing VTE, including DVT and PE, after joint arthroplasty, without increasing complications.

DOI: 10.2106/JBJS.24.00946

Hong Z, Su Y, Zhang L, Luo H

The Journal of bone and joint surgery. American volume, 2025-04-04

Interpretable machine learning model for early prediction of disseminated intravascular coagulation in critically ill children.

Disseminated intravascular coagulation (DIC) is a thrombo-hemorrhagic disorder that can be life-threatening in critically ill children, and the quest for an accurate and efficient method for early DIC prediction is of paramount importance...

DOI: 10.1038/s41598-025-91434-w

Zhou J, Xie Y, Liu Y, Niu P, Chen H, Zeng X, Zhang J

Scientific reports, 2025-04-04

Evaluation of the IMPROVE-DD score in COVID-19 patients submitted to venous thromboembolism investigation at a hospital in Brazil.

The incidence of VTE in hospitalized COVID-19 patients was high and correlated with increased mortality. The IMPROVE-DD score effectively identified patients at risk for in-hospital VTE, suggesting it could help to identify a high-risk subgroup that may benefit from extended thromboprophylaxis.

DOI: 10.36416/1806-3756/e20240042

Ferreira RA, Zanatta L, Oliveira JB, Gomes JIC, Ritt L, Rocha ATC

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2025-04-03

Temporal trend in venous thromboembolism hospitalization rates in Brazil.

The highest admission rates were registered in wealthier regions, while a higher proportion of deaths was found in the poorer ones. This may reveal the difficulty in accessing healthcare services in the North and Northeast regions, which is reflected in the potential underdiagnosis of thromboembolic events in these regions.

DOI: 10.1590/1806-9282.20240608

Soares Oliveira Portela F, Wolosker N, Louzada ACS, Portugal MFC, Fiorelli Alexandrino da Silva M, Lopes Cintra D, Girardi GPSSM, Fioranelli A, Teivelis MP

Revista da Associacao Medica Brasileira (1992), 2025-04-03

Influence Factors Analyses of PICC-Related Bloodstream Infection, PICC-Related Venous Thrombosis, and Infected Puncture Site and Their Influence on Cancer Patients' Death: A Retrospective Cross-Sectional Study.

Overall, the influence factors of catheter-related bloodstream infection, catheter-related thrombosis and catheter-related local complication were significantly different. Moreover, catheter-related bloodstream infection was the risk factor of cancer patients' death. However, catheter-related thrombosis and catheter-related local complication were not significantly associated with patients' death.

DOI: 10.1002/cam4.70841

Weng G, Wu X, Zheng S

Cancer medicine, 2025-04-03

Point-of-care ClotPro thromboelastography to determine bleeding risk in two cats with factor XII deficiency.

CASE SERIES SUMMARY: Factor XII (FXII) deficiency is a rare autosomal recessive genetic disorder in cats, leading to singular prolonged activated partial thromboplastin clotting time (aPTT) without increased bleeding risk...

DOI: 10.1177/20551169251319138

Forer V, Doulidis PG, Steiner V, Bauer N, Kulmer LM, Luckschander-Zeller N

JFMS open reports, 2025-04-03

The emerging need to manage patient expectations of haemophilia gene therapy amidst media hype in the UK.

У данной статьи нет абстракта.

DOI: 10.1177/26330040251330317

Woollard L, Gorman R

Therapeutic advances in rare disease, 2025-04-03

Real-world evaluation of therapeutic anticoagulation for cancer-associated thromboembolism: A retrospective analysis.

BackgroundThrombosis is the second leading cause of death in cancer patients and treatment for thrombosis and prevention for secondary prophylaxis is anticoagulation...

DOI: 10.1177/10781552251331559

Chung J, Park J, Chin-Hon J, Akerman M, Hindenburg A

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2025-04-03

Isolated superior mesenteric vein thrombosis in an adult with nephrotic syndrome due to minimal change disease: a case report.

This unique case underscores the importance of early recognition and appropriate management of thromboembolic events in nephrotic syndrome. By presenting this case, we aim to alert clinicians to the possibility of mesenteric venous thrombosis, a rare but potentially serious complication. Such reports are crucial in informing more effective clinical decision-making and improving outcomes for nephrotic syndrome patients.

DOI: 10.1186/s13256-025-05130-4

Dakak AG, Mahgoub MK, Jalkhi TA, Mohammed MA, Alkassar A, Amirrad M

Journal of medical case reports, 2025-04-03

Correction: Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis.

У данной статьи нет абстракта.

DOI: 10.1038/s41375-025-02587-6

Capitanio D, Calledda FR, Abbonante V, Cattaneo D, Moriggi M, Bartalucci N, Bucelli C, Tosi D, Gianelli U, Vannucchi AM, Iurlo A, Gelfi C, Balduini A, Malara A

Leukemia, 2025-04-03

Magnesium, fibrinolysis and clotting interplay among children and adolescents with type 1 diabetes mellitus; potential mediators of diabetic microangiopathy.

Children and adolescents with T1DM have lower magnesium levels than controls; that is more pronounced among those having microangiopathy. Low serum magnesium is associated with poor glycemic control, coagulopathy, and diabetic microangiopathy among children and adolescents with T1DM. Magnesium supplementation combined with standard insulin therapy in pediatric patients with T1DM is recommended for better glycemic control and prevention of diabetic microangiopathy.

DOI: 10.1038/s41387-025-00368-9

Toaima DN, Abdel-Maksoud KS, Atef HM, Salah NY

Nutrition & diabetes, 2025-04-03

Multifaceted challenges of deep venous thrombosis in the setting tetraplegia and ulcerative colitis: case report.

Both UC and traumatic SCI increase have risk of thrombosis. UC exacerbations and bleeding pose challenges in the treatment of DVT. The need to discontinue anticoagulation due to bleeding risk led to a significant progression of the DVT. SCI bowel program required careful adjustments in the setting of an UC exacerbation, likely triggered by clostridium difficile infection.

DOI: 10.1038/s41394-025-00703-3

Mapelli P, Wright M, Hrdlicka H, Rosenblum D

Spinal cord series and cases, 2025-04-03

Impact of hematocrit on coagulation measured by rotational thromboelastometry in healthy subjects and patients with polycythemia.

Thrombotic and cardiovascular events are among the leading causes of death for patients with polycythemia, more specifically for those with primary origin...

DOI: 10.1055/a-2570-4455

Martin M, Nader E, Rezigue H, Dargaud Y, Renoux C, Joly P, Heiblig M, Nougier C, Connes P

Seminars in thrombosis and hemostasis, 2025-04-03

Venous and arterial thrombosis in patients receiving immune checkpoint inhibitors.

Patients receiving ICPi have elevated risks of venous thrombosis and arterial thrombosis. Occurrence of venous thrombosis or arterial thrombosis during treatment with ICPi is associated with an increased mortality risk.

DOI: 10.1371/journal.pone.0321112

van Lent A, Puscasu R, Kaasjager KAH, Haitjema S, Suelmann BBM, Verhaar MC, Khairoun M, Ocak G

PloS one, 2025-04-03

Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.

The soluble variant of the ectopeptidase CD13 (sCD13), released from the cell surface by matrix metalloproteinase 14 (MMP14), is a potent pro-inflammatory mediator, displaying chemotactic, angiogenic, and arthritogenic properties through bradykinin receptor B1 (B1R)...

DOI: 10.1172/jci.insight.184975

Tsou PS, Ali RA, Lu C, Sule G, Carmona-Rivera C, Lucotti S, Ikari Y, Wu Q, Campbell P, Gurrea-Rubio M, Maeda K, Fox SE, Brodie WD, Mattichak MN, Foster C, Tambralli A, Yalavarthi S, Amin MA, Kmetova K, Mazetto Fonseca B, Chong E, Zuo Y, Maile M, Imbe

JCI insight, 2025-04-03

A Hemophilia Joint Health Score-Based Model for the Economic Evaluation of Hemophilia A Prophylaxis Interventions.

This is the first cost-effectiveness model incorporating HJHS to apply sequential joint damage to hemophilia A. While EA offers clinical benefits, our analysis suggests it will not be cost-effective from a Canadian provincial Ministry of Health perspective without a significant price decrease.

DOI: 10.1007/s40273-025-01484-1

Hirniak S, Edginton AN, Iorio A, Wong WWL

PharmacoEconomics, 2025-04-03

Investigating the association between antiphospholipid syndrome and ovarian reserve: A systematic review and meta-analysis of the literature.

BackgroundAutoimmune diseases can reduce ovarian reserves...

DOI: 10.1177/09612033251332051

Hemmati N, Sahebari M, Larki M, Ghavami V, Manouchehri E

Lupus, 2025-04-03

Transcription Factor FOXD3 Regulates ELAV1/TLR4 Axis in Antiphospholipid Syndrome to Mediate Proliferation and Migration of Trophoblasts.

This study focused on exploring the mechanism of transcription factor FOXD3 promoting the proliferation, migration, and invasion of trophoblast through ELAV1/TLR4 axis...

DOI: 10.1002/mrd.70021

Huang X, Qiu L, Huang S, Liang D, Chen X

Molecular reproduction and development, 2025-04-03

Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism.

Therapeutic anticoagulation is essential to prevent and treat venous and arterial thromboembolism...

DOI: 10.1038/s41569-025-01144-z

Capodanno D, Alexander JH, Bahit MC, Eikelboom JW, Gibson CM, Goodman SG, Kunadian V, Lip GYH, Lopes RD, Mehran R, Mehta SR, Patel MR, Piccini JP, Rao SV, Ruff CT, Steg PG, Weitz JI, Angiolillo DJ

Nature reviews. Cardiology, 2025-04-03

Analysis on the causes of unsatisfactory prevention effect of postpartum VTE in Chinese women.

Preventing venous thromboembolism (VTE) in obstetrics remains challenging, with cases still occurring despite preventive measures...

DOI: 10.1038/s41598-025-95790-5

Xu Y, Xiao F, He J, Xue X, Li Y, Zhu S

Scientific reports, 2025-04-03

Anticoagulant and angiotensin-converting enzyme inhibitory activities of a fucoidan from and its low molecular weight fragments prepared by acid degradation.

A purified fucoidan SF (348 kDa) was isolated from Sargassum horneri...

DOI: 10.1080/14786419.2025.2478530

Liu X, Zhao W, Gai X, Zhang M, Cui T, Du H, Jia A

Natural product research, 2025-04-03

In adults treated with OACs after a first VTE, NSAID use was linked to increased risk for bleeding.

GIM/FP/GP: [Formula: see text] Hematology: [Formula: see text]..

DOI: 10.7326/ANNALS-25-00368-JC

Barnes GD,

Annals of internal medicine, 2025-04-03

Benefit-Risk Assessment of Rivaroxaban in Older Patients With Nonvalvular Atrial Fibrillation or Venous Thromboembolism.

This analysis demonstrated a positive benefit-risk profile with rivaroxaban versus trial comparators in older patients with NVAF or VTE, with benefit-risk increasingly favoring rivaroxaban with increasing age.

DOI: 10.1007/s40266-025-01192-7

Dobesh PP, Volkl AA, Pap ÁF, Damaraju CV, Levitan B, Yuan Z, Amin AN

Drugs & aging, 2025-04-03

Impact of CYP2C19 polymorphism testing on the risk of stent thrombosis in patients with carotid artery stenting.

CYP2C19 polymorphism was not related to stent thrombosis in patients with CAS.

DOI: 10.1080/14622416.2025.2478810

Yuan HW, Huang X, Pan MY, Chen XY, Hu YZ, Lin MH, Wang JE, Wu Y, Hu J, Cao ML, Liang H

Pharmacogenomics, 2025-04-03

Five-decades of successive establishment of hemophilia care in Thailand.

Hemophilia care in Thailand constitutes the real-world experience passing from generation to generation for five decades using our limited resources efficiently.

DOI: 10.1080/17474086.2025.2486378

Chuansumrit A, Sriphaisal T, Krutvecho T, Sirachainan N, Kitpoka P, Pitakcharoen M, Jaovisidha S, Panburana P, Suwannuraks M, Sri-Udomporn N, Kijkunasathian C, Nateserinilkul R, Pongtanakul B, Traivaree C, Komvilaisak P, Sosothikul D, Lektrakul Y, Nu

Expert review of hematology, 2025-04-03

Randomized controlled trial evaluating the benefit of the app-based clinical decision support system for the management of venous thromboembolism.

App-based CDSS (DECIDE-COAG®) demonstrates a significant improvement in the accuracy of anticoagulant prescriptions and VTE management. Further studies that specifically investigate the clinical benefits of app-based CDSS in real-world clinical practice are warranted.

DOI: 10.1186/s12909-025-07014-z

Chairat P, Niprapan P, Hantrakun N, Tantiworawit A, Punnachet T, Piriyakhuntorn P, Rattanathammethee T, Hantrakool S, Rattarittamrong E, Norasetthada L, Chai-Adisaksopha C

BMC medical education, 2025-04-03

Out-of-pocket costs for direct oral anticoagulants and prescription abandonment among patients with nonvalvular atrial fibrillation or venous thromboembolism.

Among patients with NVAF or VTE, OOP costs of the first DOAC claim greater than or equal to $100 were associated with the highest risk of abandoning the first DOAC prescription.

DOI: 10.18553/jmcp.2025.31.4.366

Zhdanava M, Ashton V, Korsiak J, Jiang F, Pilon D, Alberts M

Journal of managed care & specialty pharmacy, 2025-04-03

Conservative Management of Thrombotic Microangiopathy in a Renal Transplant Recipient: The Importance of Early Recognition.

Thrombotic microangiopathy (TMA) is a rare but severe complication in renal transplant recipients, often linked to tacrolimus...

DOI: 10.1002/ccr3.70351

Matarneh AS, Sardar S, Akkari AR, Mohan P, Trivedi N, Kaur G, Ghahramani N

Clinical case reports, 2025-03-31

A Descriptive 5-Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021.

Immune thrombotic thrombocytopenic purpura (iTTP) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and microvascular occlusion secondary to acquired ADAMTS13 deficiency...

DOI: 10.1002/jca.70017

Jacobs JW, Adkins BD, Booth GS, Stanek CG, Allen ES, Grossman BJ, Stephens LD, Crowe EP, Daou L, Marques MB, Siniard RC, Wallace LR, Yamada C, Duque MA, Wu Y, Aljuboori O, Harrington TJ, Byrnes DM, Eichbaum Q, Figueroa Villalba CA, Juskewitch JE, Kla

Journal of clinical apheresis, 2025-04-03

Understanding Reasons for Oral Anticoagulation Nonprescription in Atrial Fibrillation Using Large Language Models.

This is the first study using large language models to extract documented reasons for OAC nonprescription from clinical notes in patients with atrial fibrillation and reveals guideline-discordant practices and actionable insights for the development of health system interventions to reduce OAC nonprescription.

DOI: 10.1161/JAHA.124.040419

Somani S, Kim DD, Perez-Guerrero E, Ngo S, Seto T, Al-Kindi S, Hernandez-Boussard T, Rodriguez F

Journal of the American Heart Association, 2025-03-31

Effect of periprocedural anticoagulation on patient outcomes after transcatheter edge to edge repair of mitral valve with MitraClip; an insight from nationwide dataset.

DAPT has comparable results to anticoagulation after TEER with MitraClipTM in terms of stroke prevention, bleeding and 30-days readmission with the exception of patients with atrial fibrillation, who benefit from anticoagulation. Prospective studies are needed to clarify the importance of periprocedural anticoagulation and to reduce readmissions.

DOI: 10.1016/j.ijcha.2025.101644

Ahmad S, Albaeni A, Salehin S, Abdelmaseih R, Zhang Y, Hasan SM, Rangasetty U, Gilani SA, Motiwala A, Jneid H

International journal of cardiology. Heart & vasculature, 2025-04-03

Aspirin for Venous Thromboembolism Prophylaxis and Nonsteroidal Anti-inflammatory Agents Should Be Administered at Least 2 Hours Apart.

У данной статьи нет абстракта.

DOI: 10.1016/j.artd.2025.101663

Grosso MJ

Arthroplasty today, 2025-04-03

Characterization and anticoagulation treatment patterns of hospitalized patients with nonvalvular atrial fibrillation in Spain: The CARISMA registry.

Before hospitalization, a quarter of patients with NVAF were not receiving anticoagulation medication. Hospitalization increased the proportion of patients receiving DOAC, but about a quarter of patients had off-label dosing prescriptions.

DOI: 10.1016/j.ijcha.2025.101639

Fácila L, Cordero A, Valverde Tavira A, Rilo Miranda I, Laskibar Asua A, Tirapu L, Montagud V, Sánchez-Serna J, Gómez-Mariscal E, Mainar L, Martín Dorado E, Lorenzo N, Pello Lázaro AM, Rodríguez-Mañero M

International journal of cardiology. Heart & vasculature, 2025-04-03

A device specifically designed for the treatment of cerebral venous sinus thrombosis.

У данной статьи нет абстракта.

DOI: 10.1093/nsr/nwaf046

Fisher M

National science review, 2025-04-03

Renal function decline in Asian patients with atrial fibrillation with warfarin and non-vitamin K antagonist oral anticoagulants: A report from the COOL-AF registry.

In this prospective cohort of Asian patients with AF, DOACs were associated with a slower rate of eGFR decline when compared with warfarin. In the latter group, this was irrespective of the quality of anticoagulation control.

DOI: 10.1002/joa3.70037

Krittayaphong R, Treewaree S, Yindeengam A, Lip GYH

Journal of arrhythmia, 2025-04-03

Intermittent fasting inhibits platelet activation and thrombosis through the intestinal metabolite indole-3-propionate.

Platelet hyperreactivity contributes significantly to thrombosis in acute myocardial infarction and stroke...

DOI: 10.1093/lifemeta/loaf002

Qi Z, Zhou L, Dai S, Zhang P, Zhong H, Zhou W, Zhao X, Xu H, Zhao G, Wu H, Ge J

Life metabolism, 2025-04-03

Thrombotic Microangiopathy: A Devastating Complication After Lung Transplantation.

TMA poses a significant risk of end-stage renal disease and mortality after LTx. Challenges remain in standardizing diagnostic criteria and understanding its pathogenesis, underscoring the need for unified protocols in diagnosis and standardized screening. This study identifies potential risk factors and temporal patterns for TMA occurrence, providing crucial insights for future treatment strategies.

DOI: 10.1097/TXD.0000000000001758

Rosseels W, Godinas L, Jallah P, Vos R, Dupont L, Kuypers D, Vanhoutte T, Claes KJ

Transplantation direct, 2025-04-03

The Role of Mitochondrial DNA Copy Number in Venous Thromboembolism: Insights from a 2-Sample Mendelian Randomization Study.

Our findings did not support a causal effect of mtDNA-CN in the development of VTE, but provide direct evidence that VTE may lead to reduced mtDNA-CN levels. These results suggest that mtDNA-CN as a biomarker of VTE in clinical practice.

DOI: 10.1016/j.avsg.2025.01.013

Xiang C, Zheng M, Li Y, Wang X, Liu F, Zhang C, Bu F, Lan H, Zhang F

Annals of vascular surgery, 2025-04-03

Perioperative Anticoagulation: Considerations Impacting Outcomes.

У данной статьи нет абстракта.

DOI: 10.1097/AIA.0000000000000474

Kumar M, Oprea AD

International anesthesiology clinics, 2025-04-03

Genetic testing for children at risk to be hemophilia carriers.

Carriers for hemophilia are at risk for bleeding despite normal or mildly reduced factor 8 or factor 9 activity levels...

DOI: 10.1002/jgc4.2024

Maher KN, Bergstrom K

Journal of genetic counseling, 2025-04-03

Iliofemoral Acute Deep Venous Thrombosis, Chronic Deep Venous Thrombosis, and May-Thurner Syndrome.

Acute iliofemoral deep vein thrombosis (DVT) is associated with higher rates of severe chronic symptoms and complications, and in rare cases with acute limb ischemia...

DOI: 10.1016/j.iccl.2024.11.014

Teta A, Mohan J, Varghese V, George JC, Powers J, Armstrong EJ, Castro-Dominguez Y

Interventional cardiology clinics, 2025-04-03

Risk Stratification for Venous Thromboembolism Prophylaxis.

Current risk stratification scores provide some guidance in determining the possibility of a venous thromboembolism (VTE) event following total joint arthroplasties (TJA)...

DOI: 10.1016/j.ocl.2024.09.003

Mansour E, Ganz MP, Scuderi GR

The Orthopedic clinics of North America, 2025-04-03

Expression of Recombinant Tissue Plasminogen Activator - Plasminogen Activator Inhibitor Complex in Mammal Cells as Quality Control Materials in Immunoassay.

Tissue plasminogen activator - plasminogen activator inhibitor complex (tPAIc) is a critical biomarker to assess fibrinolytic dysfunction, which is widely used in clinics...

DOI: 10.1007/s10930-025-10257-w

Yang Y, Zhang Z, Luo H, Chen C, Liu T, Lin G, Wu Y

The protein journal, 2025-04-03

Thermo-sensitive ε-polylysine-heparin-poloxamer hydrogel-encapsulated BMSCs promote endometrial regeneration.

Endometrium plays a key role in embryo implantation and maintenance of pregnancy...

DOI: 10.1016/j.mtbio.2025.101580

Han R, Zhou H, Liang X, He S, Sun X, Guan Y, Song Y

Materials today. Bio, 2025-04-03

Factor XI/XIa inhibitors: a potential solution to anticoagulation dilemmas.

FXI/XIa inhibitors offer several advantages over DOACs in stroke prevention such as reduced bleeding, fewer drug interactions, and less renal elimination. However, clinical trials must demonstrate non-inferior efficacy and improved safety compared to DOACs. Additional barriers to use will include cost, inadequacy of antidotes, and overall anticoagulant underutilization. The potential for a small molecule or monoclonal antibody to reach the clinic is very high.

DOI: 10.1080/14656566.2025.2475192

Gibson CM, Desai UR, Wesling ME

Expert opinion on pharmacotherapy, 2025-04-03

Novel Genotoxic Impurities in the First-Line Oral Anticoagulant Drug, Apixaban: Computational Toxicological Evaluation and Development of a Highly Sensitive LC-MS/MS Quantification Method.

Apixaban is an oral anticoagulant classified as a direct factor Xa inhibitor...

DOI: 10.1002/bmc.70043

Vallamkonda B, Yarguntla SR, Challa RR

Biomedical chromatography : BMC, 2025-04-03

Impact of COVID-19 pandemic on the prescribing pattern of oral anticoagulants in the English primary care setting: a population-based segmented interrupted time series analysis of over 53 million individuals.

The COVID-19 pandemic significantly impacted oral anticoagulant prescribing patterns in England. While DOAC utilisation continued to rise, warfarin use declined significantly post-first lockdown but rebounded after the second lockdown.

DOI: 10.1080/17512433.2025.2473613

Kurdi A, Albutti A, Darweesh O, Amen KM, Baker K, Karwi H, Godman B

Expert review of clinical pharmacology, 2025-04-03

Application of a Value Framework to Determine the Value of Prophylaxis Versus On-Demand Treatment in Adults with Hemophilia A in China.

The hemophilia value framework affirmed value of prophylaxis for adult patients with hemophilia A versus on-demand treatment, with benefit in terms of clinical value, economic value, patient value, and social value. The study also demonstrates that the value framework is an excellent tool for assisting stakeholders in decision-making that is grounded in patient-centered value in China.

DOI: 10.1007/s12325-025-03131-9

Tan B, Lin A, Han R, Bai L, Sun J, Hu S, Xuan J

Advances in therapy, 2025-04-03

Venous thromboembolism in children with Hodgkin lymphoma - A population-based study in Sweden, Finland, and Denmark.

VTE is a common complication in adolescents treated for HL with large tumor burden at diagnosis. Prospective studies should focus on identifying patients who would benefit from thromboprophylaxis.

DOI: 10.1016/j.thromres.2025.109287

Giertz M, Aarnivala H, Michelsen SW, Björklund C, Grönroos M, Hjalgrim LL, Huttunen P, Niinimäki R, Pöyhönen T, Raittinen P, Ranta S, Svahn JE, Törnudd L, Englund A, Harila A

Thrombosis research, 2025-04-03

Association between anticoagulant-related bleeding and mortality in patients with hematological malignancies and cancer-associated venous thromboembolism.

In this cohort of patients with hematological malignancies and newly diagnosed VTE initiated on AC therapy, bleeding was associated with an increased risk of mortality within 12 months. Association was highest with intracranial and gastrointestinal bleeding.

DOI: 10.1016/j.thromres.2025.109284

Wang TF, Luo S, Gage BF, Schoen MW, Afzal A, Carson K, Chang SH, Mahmoud A, Sanfilippo KM

Thrombosis research, 2025-04-03

Mitochondrial DNA copy number and its association with venous thromboembolism in patients with cancer.

Venous thromboembolism (VTE) is a common and serious complication among cancer patients...

DOI: 10.1016/j.thromres.2025.109285

Vostatek R, Trappl M, Englisch C, Hohensinner P, Preusser M, Pabinger I, Ay C

Thrombosis research, 2025-04-03

Pulmonary artery intimal sarcoma mimicking pulmonary thromboembolism: A case report and literature review.

Pulmonary artery intimal sarcoma (PAIS) is a rare and highly aggressive form of hemangiosarcoma...

DOI: 10.3892/ol.2025.14915

Huang Y, Wang Y, Kong B, Zheng F, Ding Y, Hayford B, Guo J, Qin R

Oncology letters, 2025-04-03

Rhythmic deep-brain magnetic stimulation promotes angiogenesis and inhibits apoptosis by regulating the JAK2/STAT3 pathway in rats with superior sagittal sinus thrombosis.

The purpose of this study is to investigate the therapeutic value of rhythmic deep-brain magnetic stimulation (rDMS) and its potential mechanisms in Sprague-Dawley rats with superior sagittal sinus thrombosis (SSST)...

DOI: 10.1016/j.brainres.2025.149509

Li M, Chen J, Meng R, Ji X

Brain research, 2025-04-03

Does hospitalisation improve oral anticoagulant optimisation in patients with atrial fibrillation?

Hospitalisation improved OAC therapy appropriateness; however, 51.0% of patients admitted with inappropriate therapy continued without correction. An intervention that enhances the hospital care team correcting inappropriate OAC therapy is warranted.

DOI: 10.1111/eci.70011

Kefale B, Peterson GM, Mirkazemi C, Dwyer NB, Salahudeen MS, Radford J, Boland CM, Bezabhe WM

European journal of clinical investigation, 2025-04-03

Excess risk of bleeding in patients with venous thromboembolism on direct oral anticoagulants during initial and extended treatment versus population controls.

The excess bleeding risk from anticoagulant treatment was high during initial treatment, particularly among females and the elderly, but lower and not influenced by sex or age during extended treatment.

DOI: 10.1111/joim.20067

Glise Sandblad K, Rosengren A, Schulman S, Roupe M, Sandström TZ, Philipson J, Svennerholm K, Tavoly M

Journal of internal medicine, 2025-04-03

Chronic thromboembolic pulmonary hypertension: Role of imaging in diagnosis and guiding the treatment.

Chronic thromboembolic pulmonary hypertension is a life-threatening condition resulting from unresolved thromboemboli that obstructs pulmonary arteries, leading to increased pulmonary vascular resistance and right heart failure...

DOI: 10.1016/j.clinimag.2025.110430

Jaramillo C, Tabaza S, Ferguson E, Odisio E, Ocazionez D, Duran C, Akkanti B, Awiwi M, Hanna M

Clinical imaging, 2025-04-03

Beyond the guidelines: original research on real-world outcomes of anticoagulation and corticosteroid in COVID-19.

This study emphasizes the importance of individualized treatment strategies in hospitalized COVID-19 patients, showing that real-world outcomes of AC and CCS can differ significantly from controlled trials. These findings provide crucial insights for adapting clinical guidelines to diverse patient settings.

DOI: 10.1016/j.ijid.2025.107834

Leslie A, Chapman SA, Tessier KM, Tignanelli C, Hozayen S

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2025-04-03

Enhancing thrombosis prevention in medical devices: The role of turbulence in washout performance using FDA benchmark nozzle model.

BACKGROUND AND OBJECTIVES: Thrombosis presents a significant and potentially lethal risk in medical devices...

DOI: 10.1016/j.cmpb.2025.108647

Fang P, Wu P, Feng H, Huang H

Computer methods and programs in biomedicine, 2025-04-03

Using Implementation Science-Informed Strategies to Improve Transitions of Care for Patients with Venous Thromboembolism.

Combinations of interventions, tailored to local context and team dynamics, improved ambulatory follow-up rates and reduced VTE-related utilization. Health systems may benefit from considering novel, implementation science-informed strategies to foster improvement.

DOI: 10.1016/j.jcjq.2024.12.007

Ciemins EL, Grant CC, Tallam M, Rattelman C, Lindberg C, Williams RA, Christensen PS, Thygeson NM

Joint Commission journal on quality and patient safety, 2025-04-03

A novel antibody against GPIbα inhibits platelet function and thrombosis without increasing bleeding.

Glycoprotein Ibα (GPIbα), the initiation protein of arterial thrombosis, was selected as a target for developing new antiplatelet drugs to prevent and treat arterial thrombosis...

DOI: 10.1016/j.ijbiomac.2025.140739

Zhao L, Du J, Jin Y, Hu Y, Zhang S, Yang B, Sun C, Zhao Y, Ge X, Yan R, Liu C, Hu R, Dai K

International journal of biological macromolecules, 2025-04-03

The incidence of venous thromboembolism by type of solid cancer worldwide: A systematic review.

There is a well-established relationship between cancer and venous thromboembolism (VTE)...

DOI: 10.1016/j.canep.2025.102764

Harry J, Bucciol R, Finnigan D, Hashem H, Araki A, Othman M

Cancer epidemiology, 2025-04-03

Comparative assessment of hemostasis in septic patients and healthy controls using standard coagulation tests and whole-blood thromboelastometry.

While SCTs suggest SP are hypocoagulable, VET revealed normal coagulation initiation in more than 80 % of SP. Compared to HC, SP had increased clot propagation, firmness and elasticity, and decreased platelet-mediated clot retraction and lysis. In sepsis, VET provide more comprehensive information about hemostatic changes than SCTs.

DOI: 10.1016/j.transci.2025.104082

Scarlatescu E, Kim PY, Marchenko SP, Tomescu DR

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2025-04-03

2025 Clinical Trials Update on Hemophilia, VWD, and Rare Inherited Bleeding Disorders.

Clinical trial programs for inherited bleeding disorders feature an array of innovative prophylaxis options: engineered clotting factor concentrates, FVIIIa mimetics, gene therapies, and biologics to bolster thrombin generation (rebalancing agents)...

DOI: 10.1002/ajh.27602

Jiang D, Wang M, Wheeler AP, Croteau SE

American journal of hematology, 2025-04-03

Long-Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation.

HALT within 30 days was not associated with clinical outcomes or hemodynamic performance during long-term follow-up.

DOI: 10.1002/ccd.31435

Iwata J, Hayashida K, Arita R, Moriizumi T, Kajino A, Sakata S, Ryuzaki T, Shinada K, Tsuruta H, Yamada Y, Kato J, Takahashi T, Yamazaki M, Jinzaki M, Shimizu H, Ieda M

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2025-04-03

Bioactivities of Nostoc sp. polysaccharides: Anti-inflammatory, wound healing, cytoprotective, and anticoagulant effects.

Polysaccharides from various cyanobacterial species have attracted attention for their potential health benefits...

DOI: 10.1016/j.ijbiomac.2025.140350

Premarathna AD, Robal M, Bai RG, Ahmed TAE, Rjabovs V, Hincke MT, Tuvikene R

International journal of biological macromolecules, 2025-04-03

Low-Range Heparin and Protamine Detection: A Single-Center Prospective Diagnostic Study.

We were able to confirm that the Sonoclot slope-45 has a high sensitivity for low-dose heparin, which is retained in the setting of interacting protamine. It was insensitive to protamine in itself.

DOI: 10.1053/j.jvca.2025.01.009

Vandenheuvel M, Vierstraete L, De Somer F, Devreese KMJ, Wouters PF, De Kesel PM

Journal of cardiothoracic and vascular anesthesia, 2025-04-03

High antigen-presenting CAF levels correlate with reduced glycosaminoglycan biosynthesis-heparan sulfate/heparin metabolism in immune cells and poor prognosis in esophageal squamous cell carcinoma: Insights from bulk and single-cell transcriptome profiling.

In esophageal squamous cell carcinoma (ESCC), the tumor microenvironment (TME) is characterized by a significant accumulation of cancer-associated fibroblasts (CAFs), which play a pivotal role in the host response against tumor cells...

DOI: 10.1016/j.ijbiomac.2025.140418

Wang S, Van KV, Zheng M, Chen WL, Ma YS

International journal of biological macromolecules, 2025-04-03

Association of Sleep Traits With Venous Thromboembolism: Prospective Cohort and Mendelian Randomization Studies.

Previous research indicates an association between sleep traits and venous thromboembolism (VTE) risk, though causal relationships remain uncertain...

DOI: 10.1002/ajh.27620

Li Y, Sun F, Ji C, Yang H, Ma Z, Zhao Y, Zhao Z, Xia Y

American journal of hematology, 2025-04-03

Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study.

Our study introduces tumor marker clustering as a novel analytical approach, providing a nuanced understanding of AFP and DCP's combined utility in predicting prognosis and recurrence. Our findings highlight the independent and complementary roles of these biomarkers, particularly in NBNC-related HCC and in cases with impaired liver function. AFP and DCP remain crucial tools for recurrence risk assessment, guiding personalized management strategies, such as surveillance, neoadjuvant therapies, and tailored postoperative interventions.

DOI: 10.1016/j.gassur.2025.101980

Saegusa Y, Imaoka Y, Ohira M, Kobayashi T, Honmyo N, Hamaoka M, Onoe T, Takei D, Oishi K, Abe T, Nakayama T, Akabane M, Sasaki K, Ohdan H,

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2025-04-03

Alemtuzumab and thrombotic thrombocytopenic purpura: Analysis of an international surveillance database and systematic literature review.

In conjunction with studies of the United Kingdom's and European Union's pharmacovigilance databases, these results support the current package insert for alemtuzumab in which TTP is listed as a "warning and precaution". Increased awareness of this possible side effect, and prolonged monitoring, is warranted.

DOI: 10.1016/j.transci.2025.104081

Jacobs JW, Binns TC, Schlafer D, Woo JS, Booth GS, Adkins BD

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2025-04-03

Spontaneous Thrombosis of Brain Arteriovenous Malformation Draining Veins: Concerns on Nonhemorrhagic Symptoms.

У данной статьи нет абстракта.

DOI: 10.1161/STROKEAHA.124.049847

Torregrossa F, Coiteiro D

Stroke, 2025-04-03

Steroid-resistant nephrotic syndrome due to renal-limited thrombotic microangiopathy and membranous nephropathy after allogeneic hematopoietic stem cell transplantation successfully treated with calcineurin inhibitors.

Transplantation-associated thrombotic microangiopathy (TMA) is a severe complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) with high mortality...

DOI: 10.1007/s12185-025-03930-4

Okada S, Nishikubo M, Shimomura Y, Hiramoto N, Osaki K, Hara S, Kondo T, Ishikawa T

International journal of hematology, 2025-04-03

Pre-Induction and Post-discharge Venous Thromboembolism Chemoprophylaxis Should be Considered in Patients After Major Vascular Open Abdominal Procedures.

Although VTE incidence after vascular procedures has decreased, in-hospital VTE may be further reduced if pre-induction subcutaneous heparin is given. Furthermore, 22% VTE developed post-discharge in vascular patients, which suggests post-discharge VTE prophylaxis should be considered in selected high-risk patients.

DOI: 10.1016/j.avsg.2025.01.021

Thompson J, Li R, Peshel E, Ricotta J, Sidawy A, Nguyen BN

Annals of vascular surgery, 2025-04-03

MRI-based modelling of left atrial flow and coagulation to predict risk of thrombogenesis in atrial fibrillation.

Atrial fibrillation (AF), impacting nearly 50 million individuals globally, is a major contributor to ischaemic strokes, predominantly originating from the left atrial appendage (LAA)...

DOI: 10.1016/j.media.2025.103475

Qureshi A, Melidoro P, Balmus M, Lip GYH, Nordsletten DA, Williams SE, Aslanidi O, de Vecchi A

Medical image analysis, 2025-04-03

Impact of the COVID-19 pandemic on emergency department utilization of initial fibrinolysis for the treatment of STEMI.

Fibrinolytic therapy use increased, but only slightly, during the COVID-19 pandemic. This suggests that the healthcare system adapted quickly to changes during the pandemic in the setting of STEMI treatment.

DOI: 10.1016/j.ajem.2025.01.030

Sussman WB, Johnson CE, Weeda ER

The American journal of emergency medicine, 2025-04-03

Endovascular Therapy is Effective in Patients with Post-Thrombotic Syndrome Based on Anatomical Classification: A Multi-Center Experience.

Endovascular technique was safe and effective for the treatment of PTS and showed promising long-term prognosis. The novel classification of PTS might be feasible for the strategy of endovascular treatment.

DOI: 10.1016/j.avsg.2025.01.009

Huang Y, Xie X, Yu X, Hong X, Pan T, Lu W, Fu W, Wang L

Annals of vascular surgery, 2025-04-03

Effects of sedation on haematological, biochemical, coagulation profile, and kaolin-activated thromboelastography in rabbits.

Blood sampling and analysis are essential procedures for assessing the health status of exotic pets...

DOI: 10.1016/j.tvjl.2025.106298

Bassan T, Pastor J, Martinez-Caro J, Agulla B, Martorell J

Veterinary journal (London, England : 1997), 2025-04-03

Early coagulation disorder and the predictive value of D-dimer for deep vein thrombosis in major burn patients.

Early coagulation disorder can occur and last for over 28 days after major burn injury. The serum D-dimer level on the 7th post-burn day may be used as a risk factor to identify the individuals with high-risk of DVT among major burn patients.

DOI: 10.1016/j.burns.2025.107398

Li N, Tan J, Feng X, Li M, Qin L, Zhou J

Burns : journal of the International Society for Burn Injuries, 2025-04-03

The membrane attack complex drives thrombotic microangiopathy in complement mediated atypical hemolytic uremic syndrome.

Introduction of complement (C) inhibition into clinical practice has revolutionized the treatment of patients with complement-mediated atypical hemolytic syndrome (aHUS)...

DOI: 10.1016/j.kint.2024.12.016

Smith-Jackson K, Walsh P, Zelek WM, Hoyler T, Martinic MM, Thompson G, Gibson BG, Connelly C, Pappworth IY, Murphy MJ, Kavanagh D, Marchbank KJ

Kidney international, 2025-04-03

Combination of Biological Aging and Genetic Susceptibility Helps Identifying At-Risk Population of Venous Thromboembolism: A Prospective Cohort Study of 394 041 Participants.

Phenotypic age acceleration (PhenoAgeAccel) is a novel clinical aging indicator...

DOI: 10.1002/ajh.27605

Hu Z, Xu J, Shen R, Lin L, Su Y, Xie C, You G, Zhou Y, Huang K

American journal of hematology, 2025-04-03

Effects of Continuous Graduated Pneumatic Compression and Intermittent Pneumatic Compression on Lower Limb Hemodynamics for VTE Prophylaxis in Arthroplasty.

The CGPC device provides a substantial increase in blood flow compared to the IPC device. Its safety and effectiveness have been preliminarily validated. The CGPC device presents a promising alternative for VTE prophylaxis in arthroplasty.

DOI: 10.1111/os.14360

Li B, Li X, Zheng W, Wei S, Zhang B, Liu J, Chen Y, Wang D, Lu Q, Liu P

Orthopaedic surgery, 2025-04-03

The tissue-plasminogen activator-challenged thromboelastography provides a comprehensive assessment of fibrinolysis in the severely injured.

Tissue-plasminogen activator-TEG LY30 more accurately reflects fibrinolysis phenotypes in trauma patients than conventional TEG methods. This provides an explanation for tPA-TEG's superior performance over rTEG in predicting clinical outcomes.

DOI: 10.1097/TA.0000000000004526

Maginot ER, Moore HB, Moore EE, Bernhardt IM, Moody TB, White CM, Siddiqui H, Gawargi FI, Henry R, Chandler JG, Sauaia A, Barrett CD

The journal of trauma and acute care surgery, 2025-04-03

Myths and challenges around anticoagulation in atrial fibrillation: A practicing clinician's perspective.

У данной статьи нет абстракта.

DOI: 10.1111/eci.14390

Airaksinen KEJ, Langén V, Teppo K, Lip GYH

European journal of clinical investigation, 2025-04-03

Altered fibrin clot properties and elevated von Willebrand factor are associated with progression to permanent atrial fibrillation: A cohort study.

Suppressed fibrin clot susceptibility to lysis and elevated vWF could contribute to progression to PerAF despite anticoagulation, which suggests links between blood coagulation and AF progression.

DOI: 10.1111/eci.14384

Nowak KW, Zabczyk M, Natorska J, Polak M, Zalewski J, Undas A

European journal of clinical investigation, 2025-04-03

Three-dimensional customized artificial grafts functionalized with biomimetic softness and anticoagulant heparin-dopamine surface modification: Preclinical study for practical applications.

Artificial vascular grafts, as blood vessel substitutes, are a prime challenge in tissue engineering and biomaterial research...

DOI: 10.1016/j.ijbiomac.2025.140002

Kim CH, Kim Y, Karna S, Yoo SM, Lee JH, Kim YJ, Lee JH, Jo WM, Park SH, Kim TH

International journal of biological macromolecules, 2025-04-03

Pausing Anticoagulation in Preparation for Transcatheter Aortic Valve Implantation: Prying Open Pandora's Box.

У данной статьи нет абстракта.

DOI: 10.1053/j.jvca.2024.12.035

Nguyen L, Khoche S

Journal of cardiothoracic and vascular anesthesia, 2025-04-03

Наверх